Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription 02.02.2026 1 Dig Dis Sci 4 Eur J Gastroenterol Hepatol 1 Gut 1 J Immunol 1 J Infect Dis 1 J Med Virol 6 J Viral Hepat

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Dig Dis Sci

1. ELFEKI MA, Zhang W, Dunn W, Arab JP, et al
   Increasing Liver Transplant Listings for Alcohol-Associated Hepatitis in Younger Patients with High MELD Scores and Excellent Performance Status.
   Dig Dis Sci. 2026 Jan 27. doi: 10.1007/s10620-026-09694.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

2. TSCHAEN JM, Fernandes MV, Holanda EU, Kleimmann RF, et al
   Comparative assessment of model for end-stage liver disease, modified model for end-stage liver disease including sodium, and Maddrey's discriminant function in alcoholic hepatitis mortality: a systematic review and diagnostic meta-analysis.
   Eur J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1097/MEG.0000000000003129.
   PubMed         Abstract available
   
   
3. SALEH H, El-Mezayen H, El-Sharkawy A, Mounir M, et al
   MicroRNA hepatocellular carcinoma detect: discriminant function based on a circulating panel of microRNA for accurate diagnosis of hepatocellular carcinoma patients on top hepatitis C virus infection.
   Eur J Gastroenterol Hepatol. 2026 Jan 22. doi: 10.1097/MEG.0000000000003145.
   PubMed         Abstract available
   
   
4. MALINO D, Codoni G, Kirchner T, Engel B, et al
   Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.
   Eur J Gastroenterol Hepatol. 2026 Jan 29. doi: 10.1097/MEG.0000000000003142.
   PubMed         Abstract available
   
   
5. ABU RAHMA MZ, Hassan EA, Hasanain AFA, Omar MAM, et al
   Detectability of hepatitis B virus DNA in peripheral blood mononuclear cells following long-term nucleos(t)ide analogue therapy-induced sustained viral suppression.
   Eur J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1097/MEG.0000000000003136.
   PubMed         Abstract available
   
   

   
   Gut

6. CORNBERG M, Lampertico P
   Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection.
   Gut. 2026 Jan 28:gutjnl-2025-337281. doi: 10.1136/gutjnl-2025-337281.
   PubMed        
   
   

   
   J Immunol

7. YANG Z, Li S, Lu R, Wei Z, et al
   CARD9 orchestrates tissue damage in APAP-induced hepatitis via TREM2-mediated sensing cell death.
   J Immunol. 2026;215:vkaf222.
   PubMed         Abstract available
   
   

   
   J Infect Dis

8. FANTILLI AC, Pisano MB, Martinez Wassaf M, Di Cola G, et al
   Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study.
   J Infect Dis. 2026 Jan 28:jiaf615. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Med Virol

9. PENG W, Yuan J, Peng S, Fu L, et al
   A Novel Systemic Inflammation-Based Model for Predicting Mortality in HBV-Related ACLF.
   J Med Virol. 2026;98:e70799.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

10. LUO Q, Xu W, Zhang Y, Li X, et al
    Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.
    J Viral Hepat. 2026;33:e70141.
    PubMed         Abstract available
    
    
11. POL S, Ouzan D, Cattan L
    HCV Cure: To Bridge the Gaps in the Care Continuum.
    J Viral Hepat. 2026;33:e70138.
    PubMed        
    
    
12. SILVEIRA IB, Silva GP, Sampaio AVH, Tome MR, et al
    Synchronous Telemedicine Versus In-Person Care in Hepatitis C Treatment: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70144.
    PubMed         Abstract available
    
    
13. GARRIDO-ESTEPA M
    Impact of Direct-Acting Antivirals Availability on Hepatitis C-Related Hospitalisations After Eight Years of the Strategic Plan for Tackling Hepatitis C Implementation in Spain.
    J Viral Hepat. 2026;33:e70143.
    PubMed         Abstract available
    
    
14. HOFMEISTER MG, Yin S, Dokpesi P, Teshale EH, et al
    Epidemiology and Control of Widespread Community Hepatitis A Outbreaks in 37 U.S. States, 2016-2023.
    J Viral Hepat. 2026;33:e70137.
    PubMed         Abstract available
    
    
15. DALY S, Reid L, Buchanan R, McCulloch P, et al
    Peer Interventions for Hepatitis C Testing and Treatment in OECD Countries: A Systematic Scoping Review.
    J Viral Hepat. 2026;33:e70130.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum